Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-03 4:41 pm Sale | 13G | APELLIS PHARMACEUTICALS INC CO APLS | BlackRock Inc. BLK | 5,865,712 6.1% | -149,236 (-2.48%) | View |
| 2021-02-16 4:17 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morningside Venture Investments Ltd | 12,556,342 15.8% | 540,540 (+4.50%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | HHLR ADVISORS LTD. | 5,028,289 6.6% | 350,000 (+7.48%) | View |
| 2021-02-10 10:30 am Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | VANGUARD GROUP INC | 5,541,825 7.32% | 5,541,825 (New Position) | View |
| 2021-02-05 07:51 am Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | BlackRock Inc. BLK | 6,014,948 7.9% | 1,257,443 (+26.43%) | View |
| 2021-02-03 1:33 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | WELLINGTON MANAGEMENT GROUP LLP | 10,577,920 13.97% | 295,290 (+2.87%) | View |
| 2020-02-14 4:28 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | HHLR ADVISORS LTD. | 4,678,289 7.3% | 2,448,581 (+109.82%) | View |
| 2020-02-14 4:07 pm Sale | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Cormorant Asset Management LP | 2,700,000 3.61% | -1,802,498 (-40.03%) | View |
| 2020-02-10 09:10 am Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | WELLINGTON MANAGEMENT GROUP LLP | 10,282,630 13.74% | 5,858,788 (+132.44%) | View |
| 2020-02-05 11:25 am Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | BlackRock Inc. BLK | 4,757,505 7.4% | 1,026,879 (+27.53%) | View |
| 2020-01-28 09:57 am Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | WELLINGTON MANAGEMENT GROUP LLP | 4,423,842 6.92% | 4,423,842 (New Position) | View |
| 2019-05-24 1:46 pm Unchanged | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morningside Venture Investments Ltd | 12,015,802 19.3% | 0 (Unchanged) | View |